Table 1.

Patient demographics and diagnostic results

Study number	Age	Sex	Relevant medical history	Relevant medication at baseline	Symptoms at diagnosis	Echo	Bicycle exercise test	Ischemia in the matching territory: noninvasive detection	Final treatment advice
1	45	Male	None	None	Possible cardiac chest pain	Normal	NP	Nuclear SPECT (physical stress): negative	Conservative
2	64	Female	HT, vascular claudication	ACEI, statin	Noncardiac pain	Normal	NP	Nuclear SPECT (adenosine): negative	Conservative
3	57	Female	HT, DM2, ocular sarcoidosis	ARB	Incidental finding	Normal	Negative	Nuclear SPECT (adenosine): negative	Conservative
4	49	Female	Asthma	None	Possible cardiac chest pain	Normal	Negative	Echo (dobutamine): negative	Conservative
5	50	Female	None	None	Possible cardiac chest pain	Normal	Negative	Nuclear SPECT (physical stress): negative	Conservative
6	52	Female	None	None	Noncardiac pain	Normal	Negative	Nuclear SPECT (physical stress): negative	Conservative
7	69	Male	OHCA due to IPL infarction, PCI RCx-MO	BB, ACEI, statin	Incidental finding	Moderate LV function	NP	Nuclear SPECT (adenosine): negative	Conservative
8	41	Male	AVNRT ablation, NSTEMI with PCI RCA and RCx	BB, ACEI, statin	Incidental finding	Normal	Inconclusive	MRI (dobutamine): negative	Conservative

ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; AVNRT, atrioventricular-nodal re-entry tachycardia; BB, β-blocker; DM2, diabetes mellitus type 2; HT, hypertension; IPL, inferoposterolateral; LV, left ventricular; MO, obtuse marginal artery; MRI, magnetic resonance imaging; NP, not performed; NSTEMI, non-ST-elevation myocardial infarction; OHCA, out of hospital cardiac arrest; PCI, percutaneous coronary intervention; RCA, right coronary artery; RCx, ramus circumflex; SPECT, single photon emission computed tomography; statin, HMG-CoA reductase inhibitors.